Novel Strategies for the Prevention and Treatment of Cardiovascular Diseases: New Horizons from Pharmaceuticals to Nutraceuticals
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 4677
Special Issue Editors
Interests: nutrition; bioactive compounds; nutraceuticals; cardiovascular diseases; metabolic diseases
Interests: obesity; diabetes; nutrition; nu traceuticals; cardiometabolic diseases
Special Issue Information
Dear Colleagues,
Cardiovascular diseases have gained increasing attention because of their high prevalence and mortality worldwide.
Substantial progress has been made in developing therapies that address the risk of cardiovascular disease.
Pharmaceutical agents play a major role in the prevention of atherosclerosis and its consequences: heart attack, stroke, and heart failure. Additionally, novel device-based therapies are contributing to the decline in cardiac morbidity and mortality. A concrete hope exists that lifestyle changes, early risk factor screening, nutraceuticals, and more efficacious pharmaceuticals will reduce cardiovascular risk in the future.
In this Special Issue, we are interested in original and review articles that assess both novel strategies of prevention and clinical outcomes as a consequence of various treatment advances in this area, thus discussing future research directions. This issue should be of interest to a wide range of clinicians that encounter cardiovascular diseases, especially those who treat comorbidities.
Dr. Maria Alessandra Gammone
Prof. Dr. Nicolantonio D'orazio
Dr. Maria Giulia Gagliardi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular diseases
- overweight
- obesity
- inflammation
- hypertension
- dyslipidemia
- lifestyle
- pharmaceuticals
- nutraceuticals
- nutrition
- diabetes
- prevention
- treatment
- cardiovascular risk